Phenex Pharmaceuticals AG was founded in 2002. It is a privately held drug discovery & development company based in the Biotech Cluster Rhine-Neckar with Biology and Chemistry laboratories and offices primarily in Heidelberg and partly in Ludwigshafen. Their company focuses its small-molecule drug discovery expertise in Liver and Gastrointestinal disease areas and has now recently entered the field of Cancer Therapy. They not only devise novel therapeutics for known targets but additionally aim to identify novel molecular mechanisms. This provides the basis for the identification of novel small molecules with "game changing" capabilities. Historically, Phenex has identified two of such novel mechanisms from literature and has translated them into proprietary novel therapeutic small molecules.

Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving procedure to more patients. Over the past 50 years, stem cell transplantation has been used in more than 1M patients worldwide. It is currently the only treatment with the potential to cure some of the most devastating hematologic cancers and autoimmune diseases. Despite the increased use and clinical advancements over the past several decades, stem cell transplant remains a high-risk last-resort therapeutic option due to the toxicity and potential long-term side effects.

Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed, and biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412 and IK-007. The company was founded by Mark Manfredi and George Georgiou in February 2016 and is headquartered in Boston, MA.

Nogra Pharma Ltd. operates as a pharmaceutical company. It offers brand which include Lialda and Mezavant. The firm focuses on the treatment of ulcerative colitis and crohn's disease. The company was founded in 2005 and is headquartered in Dublin, Ireland.

Symrise GmbH & Co. KG develops and produces flavors, fragrances, cosmetic ingredients and aroma chemicals. It supplies cosmetic raw materials and active ingredients to the international fragrance, cosmetics and food industry. It's core competencies are extraction and distillation-separation techniques used to isolate natural flavor components. With its new ayurveda Extrapone product range, it offers components from traditional ayurvedic plants and herbs such as sandalwood, lotus flower, cinnamon, ginger and neem. Founded in 2003, the company is headquartered in Holzminden, Germany.

Dong-A ST Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for gastric mucous membrane protection, antihistaminic agents, ischemic improvements, antithrombotic, functional digestion, hyperlipemia cure, growth hormone, anti-peptic ulcer cure, cerebral metabolic, high blood pressure, and others. The company was founded on March 1, 2013 and is headquartered in Seoul, South Korea.

Thesan Pharmaceuticals, Inc. is a preclinical biopharmaceutical company dedicated to the development of novel therapeutics for disorders of the skin. Until recently, there has been comparatively limited innovation in the field of dermatology, where many companies have focused on the reformulation of existing drugs often resulting in marginal patient benefit. In contrast, Thesan is focused on the discovery and development of New Chemical Entities that have the potential to provide significantly improved treatment options to patients.

DKFZ Deutsche Krebsforschungszentrum is a German private company that operates as a cancer research center.

Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan.

Azora Therapeutics, Inc. is an American company located in Encino, CA. The firm operates as clinical stage biopharmaceutical company which develops novel small molecule chemical entities for the treatment of autoimmune and auto inflammatory diseases. It was founded by Matthew Davidson and Julie Saiki. Matthew Davidson is the current CEO of the firm.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Ariagen is a biotech company that develops a novel class of small molecules as cancer immunotherapies. The company was founded in 2017 and is headquartered in Menlo Park, California, United States.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Bayer Schering Pharma AG is a research-centered pharmaceutical company that was formed by the merger of Schering with Bayer on 29 December 2006. The company was originally founded in 1851 by Ernst Christian Friedrich Schering. The company employs more than 26,000 people in 140 subsidiaries all over the world. The company's headquarters are in Berlin-Wedding, Germany and the forerunner company Schering's annual gross revenue was nearly € 5 billion. They retain the largest German manufacturing facility which is located in Bergkamen. The company focuses on the business areas of gynaecology and andrology, oncology, and also special therapeutics, diagnostical devices, and nuclear medicine. Schering's best-known product is their line of combined oral contraceptive pills. Through Bayer Healthcare AG, Bayer Schering Pharma is a full member of the European Federation of Pharmaceutical Industries and Associations.

FrieslandCampina Nederland BV, a subsidiary of Zuivelco��peratie FrieslandCampina UA, is a Dutch company located in Bedum. The firm manufactures and markets cream & butter products.

Meiji Co., Ltd. produces and sells milk, dairy, confectioneries, and food. Its products include cheese, ice cream, chocolate, infant formula, whey protein, beauty supplements, and yogurt. The company was founded on December 21, 1917 and is headquartered in Tokyo, Japan.

InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden.

RCEES is a Chinese research institute that focuses on eco-environmental science and technology.